• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯喹和羟氯喹的全身毒性:流行情况、机制、危险因素、预后和筛查可能性。

Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities.

机构信息

Aix Marseille Université, Marseille, France.

出版信息

Rheumatol Int. 2021 Jul;41(7):1189-1202. doi: 10.1007/s00296-021-04868-6. Epub 2021 Apr 24.

DOI:10.1007/s00296-021-04868-6
PMID:33893862
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8064887/
Abstract

Chloroquine (CQ) and its hydroxylated analog, hydroxychloroquine (HCQ), are 4-aminoquinoline initially used as an antimalarial treatment. CQ and HCQ (4-aminoquinoline, 4-AQ) are today used in rheumatology, especially to treat rheumatoid arthritis and systemic lupus erythematosus. Their mechanism of action revolves around a singular triptych: 4-AQ acts as alkalizing agents, ionized amphiphilic molecules, and by binding to numerous targets. 4-AQ have so pleiotropic and original mechanisms of action, providing them an effect at the heart of the regulation of several physiological functions. However, this broad spectrum of action is also at the origin of various and original side effects, notably a remarkable chronic systemic toxicity. We describe here the 4-AQ-induced lesions on the eye, the heart, muscle, the nerves, the inner ear, and the kidney. We also describe their prevalence, their pathophysiological mechanisms, their risk factors, their potential severity, and the means to detect them early. Most of these side effects are reversible if treatment is stopped promptly. This 4-AQ-induced toxicity must be known to prescribing physicians, to closely monitor its appearance and stop treatment in time if necessary.

摘要

氯喹(CQ)及其羟化类似物羟氯喹(HCQ)最初是作为抗疟药物使用的 4-氨基喹啉。CQ 和 HCQ(4-氨基喹啉,4-AQ)如今在风湿病学中使用,特别是用于治疗类风湿关节炎和系统性红斑狼疮。它们的作用机制围绕着一个独特的三联体:4-AQ 作为碱化剂、离子化两亲分子,并与许多靶标结合。4-AQ 的作用机制如此多样且独特,为其提供了对多种生理功能调节的作用。然而,这种广泛的作用机制也是各种独特副作用的根源,尤其是显著的慢性全身毒性。我们在这里描述了 4-AQ 引起的眼部、心脏、肌肉、神经、内耳和肾脏损伤。我们还描述了它们的流行程度、病理生理机制、危险因素、潜在严重程度以及早期检测它们的方法。如果及时停止治疗,大多数这些副作用都是可逆的。开具处方的医生必须了解这种 4-AQ 诱导的毒性,密切监测其出现情况,并在必要时及时停止治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/715c/8064887/63e7d0c500e0/296_2021_4868_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/715c/8064887/63e7d0c500e0/296_2021_4868_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/715c/8064887/63e7d0c500e0/296_2021_4868_Fig1_HTML.jpg

相似文献

1
Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities.氯喹和羟氯喹的全身毒性:流行情况、机制、危险因素、预后和筛查可能性。
Rheumatol Int. 2021 Jul;41(7):1189-1202. doi: 10.1007/s00296-021-04868-6. Epub 2021 Apr 24.
2
How toxic is an old friend? A review of the safety of hydroxychloroquine in clinical practice.一位老友有多毒?羟氯喹在临床实践中的安全性综述。
Intern Med J. 2023 Mar;53(3):311-317. doi: 10.1111/imj.15908. Epub 2022 Aug 25.
3
Skin and ophthalmic complications of chloroquine and hydroxychloroquine in patients with rheumatoid arthritis and systemic lupus erythematous.类风湿关节炎和系统性红斑狼疮患者中氯喹和羟氯喹的皮肤和眼部并发症。
J Immunoassay Immunochem. 2024 May 3;45(3):178-188. doi: 10.1080/15321819.2024.2350544. Epub 2024 May 9.
4
Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.羟氯喹和氯喹在治疗系统性红斑狼疮、类风湿关节炎及相关疾病中的治疗和药理学特性。
Inflammopharmacology. 2015 Oct;23(5):231-69. doi: 10.1007/s10787-015-0239-y. Epub 2015 Aug 6.
5
Identification of new risk factors for hydroxychloroquine and chloroquine retinopathy in systemic lupus erythematosus patients.识别系统性红斑狼疮患者羟氯喹和氯喹视网膜病变的新风险因素。
Semin Arthritis Rheum. 2024 Jun;66:152417. doi: 10.1016/j.semarthrit.2024.152417. Epub 2024 Feb 12.
6
Long-term effectiveness of antimalarial drugs in rheumatic diseases.抗疟药物在风湿性疾病中的长期疗效。
Ann Rheum Dis. 1998 Oct;57(10):582-7. doi: 10.1136/ard.57.10.582.
7
Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.羟氯喹和氯喹:评估视网膜毒性风险。
J Am Optom Assoc. 1993 Nov;64(11):787-97.
8
Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates.氯喹和羟氯喹所致的眼毒性:电生理与视觉功能的相关性
Doc Ophthalmol. 2005 Jan;110(1):111-20. doi: 10.1007/s10633-005-7349-6.
9
Hydroxychloroquine and Chloroquine-Induced Cardiac Arrhythmias and Sudden Cardiac Death in Patients With Systemic Autoimmune Rheumatic Diseases: A Systematic Review and Meta-Analysis.羟氯喹和氯喹引起的系统性自身免疫性风湿病患者的心律失常和心源性猝死:系统评价和荟萃分析。
J Cardiovasc Pharmacol. 2024 Aug 1;84(2):158-169. doi: 10.1097/FJC.0000000000001589.
10
Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine.经频域光学相干断层扫描测量羟氯喹治疗患者的视网膜功能变化。
Graefes Arch Clin Exp Ophthalmol. 2011 May;249(5):715-21. doi: 10.1007/s00417-010-1612-6. Epub 2011 Jan 21.

引用本文的文献

1
Early-onset bull's eye maculopathy due to hydroxychloroquine in rheumatoid arthritis and myasthenia gravis.类风湿关节炎和重症肌无力患者中由羟氯喹引起的早发性靶形黄斑病变
Int J Ophthalmol. 2025 Sep 18;18(9):1809-1811. doi: 10.18240/ijo.2025.09.25. eCollection 2025.
2
Unc-51 Like Kinase 3 (ULK3) is essential for autophagy and cell survival in multiple myeloma.Unc-51样激酶3(ULK3)对多发性骨髓瘤中的自噬和细胞存活至关重要。
Res Sq. 2025 Aug 12:rs.3.rs-7160521. doi: 10.21203/rs.3.rs-7160521/v1.
3
Integrating Chemo- and Bioinformatics with Biological Assays to Discover Potential ACE2 and Mpro Inhibitors against SARS-CoV-2.

本文引用的文献

1
American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 Joint Statement on Hydroxychloroquine Use With Respect to Retinal Toxicity.美国风湿病学会、美国皮肤病学会、风湿病皮肤病学会和美国眼科学会 2020 年关于羟氯喹视网膜毒性的联合声明
Arthritis Rheumatol. 2021 Jun;73(6):908-911. doi: 10.1002/art.41683. Epub 2021 Apr 26.
2
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.羟氯喹治疗 COVID-19 住院患者的疗效。
N Engl J Med. 2020 Nov 19;383(21):2030-2040. doi: 10.1056/NEJMoa2022926. Epub 2020 Oct 8.
3
将化学信息学和生物信息学与生物学检测相结合,以发现针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的潜在血管紧张素转换酶2(ACE2)和主要蛋白酶(Mpro)抑制剂。
J Chem Inf Model. 2025 Aug 11;65(15):8249-8261. doi: 10.1021/acs.jcim.5c01056. Epub 2025 Jul 25.
4
Cutaneous Adverse Effects of Hydroxychloroquine and Leflunomide in Connective Tissue Diseases: A Report of Three Cases and a Literature Review.羟氯喹和来氟米特在结缔组织病中的皮肤不良反应:三例报告及文献综述
Cureus. 2025 Jun 7;17(6):e85495. doi: 10.7759/cureus.85495. eCollection 2025 Jun.
5
Chloroquine and hydroxychloroquine: Immunomodulatory effects in autoimmune diseases.氯喹和羟氯喹:在自身免疫性疾病中的免疫调节作用
World J Biol Chem. 2025 Jun 5;16(2):107042. doi: 10.4331/wjbc.v16.i2.107042.
6
A new 3-arylbenzofuran derivative EIE-2 reestablishes Treg-dependent tolerance in rheumatoid arthritis by targeting on Syk induced mTOR and PKCθ imbalance.一种新型3-芳基苯并呋喃衍生物EIE-2通过靶向Syk诱导的mTOR和PKCθ失衡,重新建立类风湿性关节炎中Treg依赖的耐受性。
Front Immunol. 2025 May 21;16:1524491. doi: 10.3389/fimmu.2025.1524491. eCollection 2025.
7
Hydroxychloroquine-Induced Hepatotoxicity in Systemic Lupus Erythematous: A Case Report and Literature Review.系统性红斑狼疮中羟氯喹诱导的肝毒性:一例报告及文献综述
Cureus. 2025 Apr 3;17(4):e81664. doi: 10.7759/cureus.81664. eCollection 2025 Apr.
8
Influence of CYP2C8 Polymorphism on the Exposure to Chloroquine in Patients with Malaria by -A Preliminary Study.CYP2C8基因多态性对疟疾患者氯喹暴露量的影响——一项初步研究
Int J Environ Res Public Health. 2025 Feb 25;22(3):336. doi: 10.3390/ijerph22030336.
9
Screening of patient-derived organoids identifies mitophagy as a cell-intrinsic vulnerability in colorectal cancer during statin treatment.对患者来源的类器官进行筛选发现,线粒体自噬是他汀类药物治疗期间结直肠癌的一种细胞内在脆弱性。
Cell Rep Med. 2025 Apr 15;6(4):102039. doi: 10.1016/j.xcrm.2025.102039. Epub 2025 Mar 27.
10
Hydroxychloroquine: A double‑edged sword (Review).羟氯喹:一把双刃剑(综述)
Mol Med Rep. 2025 Apr;31(4). doi: 10.3892/mmr.2025.13467. Epub 2025 Feb 21.
Predictive factors for cardiac conduction abnormalities with hydroxychloroquine-containing combinations for COVID-19.
羟氯喹联合治疗 COVID-19 导致心脏传导异常的预测因素。
Int J Antimicrob Agents. 2020 Oct;56(4):106142. doi: 10.1016/j.ijantimicag.2020.106142. Epub 2020 Aug 24.
4
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.羟氯喹或联合阿奇霉素治疗轻中度 COVID-19。
N Engl J Med. 2020 Nov 19;383(21):2041-2052. doi: 10.1056/NEJMoa2019014. Epub 2020 Jul 23.
5
Retrospective analysis of dermatologic adverse events associated with hydroxychloroquine reported to the US Food and Drug Administration.对向美国食品药品监督管理局报告的与羟氯喹相关的皮肤不良事件进行回顾性分析。
J Am Acad Dermatol. 2020 Nov;83(5):1527-1529. doi: 10.1016/j.jaad.2020.07.007. Epub 2020 Jul 8.
6
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis.法国马赛接受羟氯喹/阿奇霉素和其他方案治疗的 3737 例 COVID-19 患者的结局:一项回顾性分析。
Travel Med Infect Dis. 2020 Jul-Aug;36:101791. doi: 10.1016/j.tmaid.2020.101791. Epub 2020 Jun 25.
7
Cardiovascular Toxicities Associated With Hydroxychloroquine and Azithromycin: An Analysis of the World Health Organization Pharmacovigilance Database.羟氯喹啉和阿奇霉素相关的心血管毒性:世界卫生组织药物警戒数据库分析
Circulation. 2020 Jul 21;142(3):303-305. doi: 10.1161/CIRCULATIONAHA.120.048238. Epub 2020 May 22.
8
Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin.羟氯喹和阿奇霉素治疗的 COVID-19 患者的心律失常谱和 24 小时 QT 间期变异性。
Int J Cardiol. 2020 Oct 1;316:280-284. doi: 10.1016/j.ijcard.2020.05.036. Epub 2020 May 19.
9
Lysosomotropic drugs enhance pro-inflammatory responses to IL-1β in macrophages by inhibiting internalization of the IL-1 receptor.溶酶体靶向药物通过抑制白细胞介素-1 受体的内化来增强巨噬细胞对白细胞介素-1β 的促炎反应。
Biochem Pharmacol. 2020 May;175:113864. doi: 10.1016/j.bcp.2020.113864. Epub 2020 Feb 20.
10
pH-dependent transport kinetics of the human organic anion-transporting polypeptide 1A2.人有机阴离子转运多肽 1A2 的 pH 依赖性转运动力学。
Drug Metab Pharmacokinet. 2020 Apr;35(2):220-227. doi: 10.1016/j.dmpk.2019.12.002. Epub 2019 Dec 24.